ProPhase Labs appoints Bill White as CFO effective May 23, 2022

ProPhase Labs, Inc.

Bill White, 61, replaces Monica Brady, who becomes CAO and CFO of subsidiary ProPhase Diagnostics.
White previously CFO/COO of Intellicheck (IDN); over 30 years financial management experience.
Salary $350k; minimum 2022 bonus $50k; inducement option for 400k shares at $6.74, vesting 4 years.
Severance: 6 months salary if terminated without cause before 1 year; 12 months after 1 year.
Inducement option exempt from stockholder approval per Nasdaq Rule 5635(c)(4).

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Bill White

Chief Financial Officer

PRPH · ProPhase Labs, Inc.

Effective: 2022-05-23
Filed: May 10, 2022, 7:59 PM ET

On May 9, 2022, ProPhase Labs, Inc. (the “Company”) announced that it will appoint Bill White, age 61, as Chief Financial Officer of the Company, effective May 23, 2022

Role change

Monica Brady

Chief Accounting Officer and Chief Financial Officer of subsidiary

PRPH · ProPhase Labs, Inc.

Effective: 2022-05-23
Successor: Bill White
Filed: May 10, 2022, 7:59 PM ET

Ms. Brady will remain with the Company and continue to serve as the Company’s Chief Accounting Officer, and Chief Financial Officer of the Company’s wholly-owned subsidiary, ProPhase Diagnostics, Inc., as of the Effective Date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bill White was appointed as Chief Financial Officer at ProPhase Labs, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On May 9, 2022, ProPhase Labs, Inc. (the “Company”) announced that it will appoint Bill White, age 61, as Chief Financial Officer of the Company, effective May 23, 2022

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.9

Monica Brady changed role as Chief Accounting Officer and Chief Financial Officer of subsidiary at ProPhase Labs, Inc..

Action: replaced
Role: Chief Accounting Officer and Chief Financial Officer of subsidiary

Exact text from the filing

Ms. Brady will remain with the Company and continue to serve as the Company’s Chief Accounting Officer, and Chief Financial Officer of the Company’s wholly-owned subsidiary, ProPhase Diagnostics, Inc., as of the Effective Date.

View on SEC.gov

ProPhase Labs, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-012630

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.